Clinical Trials

Evaluation of CyberKnife Stereotactic Radiotherapy in Prostate Cancer

June 23rd, 2023 | Clinical Trials

NCT Number: NCT02016248 Phase: Not Applicable Trial Summary: The purpose of this study is to determine the side effects and how effective CyberKnife stereotactic ablative body radiation (SABR) is in patients with prostate cancer. The CyberKn – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): MemorialCare Health System Acronym:

HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer

June 23rd, 2023 | Clinical Trials

NCT Number: NCT01913106 Phase: Phase 1|Phase 2 Trial Summary: The purpose of this study is to conduct a Phase I – II clinical trial to extend preclinical studies involving in situ HSV-tk + Valacyclovir gene therapy in combination with brachyt – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): The Methodist Hospital Research Institute […]

CyberKnife® as Monotherapy or Boost SBRT for Intermediate or High Risk Localized Prostate Cancer

June 23rd, 2023 | Clinical Trials

NCT Number: NCT01985828 Phase: Not Applicable Trial Summary: The primary objective of this study is to document the effectiveness of Cyberknife stereotactic body radiotherapy (SBRT) in the treatment of intermediate and high-risk localized pr – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): Advocate Health Care Acronym:

Trial of Modifications to Radical Prostatectomy

June 23rd, 2023 | Clinical Trials

NCT Number: NCT01407263 Phase: Phase 3 Trial Summary: This trial will evaluate whether the following aspect of surgical technique influence outcome: Lymph node dissection. In some patients, scans taken before surgery show that a lymph – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): Memorial Sloan Kettering Cancer Center Acronym:

MR-Guided Cryoablation of Prostate Bed Recurrences

June 23rd, 2023 | Clinical Trials

NCT Number: NCT01727284 Phase: Not Applicable Trial Summary: The purpose of this research is to see if MR-guided cryoablation can effectively treat prostate tumo – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): Mayo Clinic Acronym:

[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer

June 23rd, 2023 | Clinical Trials

NCT Number: NCT00588185 Phase: Not Applicable Trial Summary: This study will use PET scans, which is a type of x-ray test that uses a radiotracer, to see whether these scans may be better able to find places in the body where your prostate c – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): Memorial […]

Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer

June 23rd, 2023 | Clinical Trials

NCT Number: NCT01492972 Phase: Phase 3 Trial Summary: The purpose of this study is to compare the effects, good and/or bad of two treatment methods on subjects and their canc – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): Proton Collaborative Group Acronym:

MRI for Assessing Prostate Cancer Response

June 23rd, 2023 | Clinical Trials

NCT Number: NCT01607008 Phase: Not Applicable Trial Summary: Prostate cancer is one of most common cancers in America, affecting 1 in 6 men. External beam radiation therapy is one of the common methods to treat prostate cancer. Although radi – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): Sidney Kimmel Comprehensive Cancer Center at […]

Pin It on Pinterest